Navigation Links
New Alzheimer's Treatment Protocol Produces Significant Results
Date:4/11/2013

MYRTLE BEACH, S.C., April 11, 2013 /PRNewswire/ -- "The Alzheimerʼs Journey" DVD series was developed by Dr. Van Horn over the past five years while he was serving as medical director of both an inpatient Alzheimerʼs unit and an outpatient clinic where he worked with hundreds of Alzheimerʼs patients and families. Unwilling to accept the conventional, often ineffective approach to Alzheimerʼs treatment, Dr. Van Horn aggressively explored new and comprehensive medication protocols that are now demonstrating significant benefits. "The Alzheimerʼs Journey," combined with his website (www.protectyourbrain.com) and his daily Alzheimer's Disease webcasts form the foundation of his mission to share his extensive clinical expertise and empower patients and families with the battle plan to "Win the War with Alzheimerʼs Disease."

(Photo:  http://photos.prnewswire.com/prnh/20130411/PH92823-a )
(Photo:  http://photos.prnewswire.com/prnh/20130411/PH92823-b

"The Alzheimerʼs Journey" is not as an esoteric, philosophical discussion about Alzheimerʼs Disease. It is not about future research. "The Alzheimer's Journey" is a comprehensive, directive series about what people and families can do right now to battle Alzheimerʼs Disease. As the host of "The Alzheimerʼs Journey," Dr. Van Horn presents medical information and treatment protocols in an entertaining and understandable format with a focus on three significant areas:

  1.  For people with intact memory, extensive and compelling information is presented on how to significantly reduce oneʼs risk of Alzheimerʼs Disease.
  2.  For people with the mild to moderate memory loss of Alzheimerʼs Disease, Dr. Van Horn details the unique treatment protocol he currently prescribes to significantly slow the progression of memory loss.
  3.  For families with loved ones who have advanced Alzheimerʼs Disease and are suffering with apathy, depression, insomnia, agitation or psychosis, Dr. Van Horn offers his comprehensive eight-step treatment process to restore dignity to the patient and relationship with the family.

"Most people and many doctors perceive Alzheimerʼs Disease as an illness that attacks old people with no intervention possible," remarked Dr. Van Horn . "My mission is not only to refute that perception, but to empower families with a detailed battle plan to win the war with Alzheimerʼs Disease. Every day I see the significant benefits of brain protection and aggressive medical treatment. Most information available about Alzheimerʼs Disease focuses on the suffering of patients and families. "The Alzheimerʼs Journey" offers the solution to the suffering. I am excited about "The Alzheimerʼs Journey" because I know it will tremendously benefit millions of families."

Previews of the entire series are available for viewing online at www.protectyourbrain.com and on Facebook at www.facebook.com/thealzheimersjourney.

About William A. Van Horn , MD

William A. Van Horn , MD is a Diplomat of the American Board of Neurology and Psychiatry with more than twenty-five years' experience helping patients maximize the quality of their lives by ensuring proper and effective medical treatment for illnesses of the brain. Dr. Van Horn completed medical school at the University of South Alabama and received specialty training in a biological and neurological based psychiatry program at West Virginia University. He also had the privilege of working with some of the top Alzheimerʼs specialists in the United States during his Fellowship in geriatric psychiatry at Emory University. Dr. Van Horn currently serves on the Board of Directors of the South Carolina Chapter of the Alzheimerʼs Association.

For more information, or to schedule an interview with Dr. Van Horn , please contact:

Jason Frahm  
Ph. (646) 541-4304  
Email

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE William A Van Horn, MD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Merrimack Pharmaceuticals Preclinical Research Shows MM-111 Restores Sensitivity To Chemotherapy And HER2-targeted Treatment In Gastric Cancer Model
2. One-Time, One Dose Radiation Treatment Offered For Breast Cancer Patients At MedStar Georgetown University Hospital And MedStar Washington Hospital Center
3. Merrimack Pharmaceuticals Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
4. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
5. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
6. Hadasit Bio-Holdings Flagship Portfolio Company Enlivex Awarded Orphan Drug Status for ApoCell Treatment by the FDA
7. Rapid Increase In Sclerosant Use Will Drive Steady Expansion Of US Varicose Vein Treatment Device Market
8. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
9. For the Treatment of Lupus, the Emerging Therapies Epratuzumab and Lupuzor Have the Potential to Offer Improvements Over IV Belimumab in Reducing Disease Activity
10. Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
11. Surveyed U.S. Physicians Indicate That Xarelto and Apixaban Will Benefit From the Lack of Use of a Fast-Acting Injectable Anticoagulant in the Treatment and Secondary Prophylaxis of Deep Vein Thrombosis/Pulmonary Embolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Germany and GERMANTOWN, Maryland ... N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) ... and co-development agreement with Therawis Diagnostics GmbH to develop and ... to develop and market PITX2 as a marker to predict ... breast cancer patients. "We are pleased to partner ...
(Date:5/25/2016)... NEW YORK , May 25, 2016  According ... devices reached $381 billion in 2015.  Though these ... still plenty of opportunity for success for companies ... end, in search of new growth prospects medical ... revenue on research and development (R&D) than do ...
(Date:5/25/2016)... May 25, 2016 As illustrated ... earlier this month, the numbers and momentum of cannabis ... climb into the billions, more research and development push ... Edition State of Legal Marijuana Markets Report  from from ... firm, much of the increase in sector is attributed ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... ... Southland Log Homes , designer and manufacturer of America’s Favorite Log ... be found on its website at SouthlandLogHomes.com. , The designs of the wood ... craftsmanship of timber post and beam construction. The result is a barn that ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 , ... ... factors of a stroke, which we as a society can control and change. , ... stroke occurs nearly every 40 seconds within the United States. Plus, with an estimated ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in the health ... of leaders in the nursing and health care industry. It also provides insight to ... Christian University. , As the nursing industry is coming out of one of ...
(Date:5/26/2016)... , ... May 26, 2016 , ... W.S. Badger ... has been honored with a 2016 When Work Works Award for its use of ... of the national When Work Works project administered by the Families and Work Institute ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... On Memorial ... and women who lost their lives in military battle for the country. The ... in 2015 to provide more programs that empower independence for disabled military veterans, as ...
Breaking Medicine News(10 mins):